SEC Form 4/A · accession 0001179110-16-031248
MADRIGAL PHARMACEUTICALS, INC. · MDGL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Keith R Gollust
Director
Period of report
Jul 22, 2016
Accepted (ET)
Nov 4, 2016 · 5:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001157601
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1,F2 | $9.45 | Jul 22, 2016 | A | 20,000 | A | — | Jul 22, 2026 | Common Stock | 20,000 | 20,000 | D |
Explanation of responses
- F1This report amends the original report to reflect the correct exercise price of $9.45 per share.
- F2Fifty percent (50%) of the option vests on July 22, 2017 and thereafter it vests at a rate of twelve and one-half percent (12.5%) per quarter for four (4) successive quarters.